National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)

Alzheimer disease trial methodology

Schneider, L. S., Tariot, P. N., Lyketsos, C. G., Dagerman, K. S., Davis, K. L., Davis, S., Hsiao, J. K., Jeste, D. V., Katz, I. R., Olin, J. T., Pollock, B. G., Rabins, P. V., Rosenheck, R. A., Small, G. W., Lebowitz, B., & Lieberman, J. A. (2001). National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. American Journal of Geriatric Psychiatry, 9(4), 346-360. https://doi.org/10.1097/00019442-200111000-00004

Abstract

The authors describe the development of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) protocol for Alzheimer disease (AD), a trial developed in collaboration with the National Institute of Mental Health (NIMH), assessing the effectiveness of atypical antipsychotics for psychosis and agitation occurring in AD outpatients. They provide an overview of the methodology utilized in the trial as well as the clinical-outcomes and effectiveness measures that were implemented.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

What are the labor market returns to MBAs from broad-access institutions?
Article

Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the United States
Article

The daily association between affect and alcohol use: A meta-analysis of individual participant data
Article

Protection of forest ecosystems in the eastern United States from elevated atmospheric deposition of sulfur and nitrogen